Fatal infection caused by Francisella tularensis in a neutropenic bone marrow transplant recipient

Annals of Hematology

Volumn 82, Issue 1, 2003, Pages 41-43

  Sarria, Juan C ^a   Vidal, A M ^a   Kimbrough, R C ^a   Figueroa, J E ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Bone marrow transplantation; Francisella tularensis; Immunocompromise; Neutropenia

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MEZLOCILLIN; PIPERACILLIN; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; COMA; DEATH; FATALITY; FRANCISELLA TULARENSIS; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE DEFICIENCY; LABORATORY TEST; LETHARGY; LEUKOCYTE COUNT; LYMPHADENOPATHY; MALE; MUSCLE WEAKNESS; NEUTROPENIA; NEUTROPHIL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RECIPIENT; ACUTE LYMPHOCYTIC LEUKEMIA; CELLULAR IMMUNITY; IMMUNOLOGY; OPPORTUNISTIC INFECTION; TULAREMIA;

ADULT; BONE MARROW TRANSPLANTATION; FATAL OUTCOME; FRANCISELLA TULARENSIS; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; TULAREMIA;

EID: 0037675077     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0570-4     Document Type: Article

References (20)

1. American Public Association (2000) Tularemia. In: Chin J (ed) Control of communicable diseases manual. American Public Health Association, Washington, DC, pp 532-535
2. Centers for Disease Control and Prevention (2002) Tularemia - United States, 1990-2000. MMWR Morb Mortal Wkly Rep 51:182-184
3. Culkin SJ, Rhinehart-Jones T, Elkins KL (1997) A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol 158:3277-3284
4. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDAde JE, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K (2001) Tularemia as a biological weapon. Medical and public health management. JAMA 285:2763-2773
5. Enderlin G, Morales L, Jacobs RF, Cross JT (1994) Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 19:42-47
6. Evans ME, Gregory DW, Schaffner W, McGee ZA (1985) Tularemia: a 30-year experience with 88 cases. Medicine 64:251-269
7. Grunow R, Splettstoesser W, McDonald S, Otterbein C, O'Brien T, Morgan C, Aldrich J, Hofer E, Finke EJ, Meyer H (2000) Detection of Francisella tularensis in biological specimens using a capture enzyme-linked immunosorbent assay, an immunochromatographic handheld assay, and a PCR. Clin Diagn Lab Immunol 7:86-90
8. Johansson A, Berglund L, Eriksoon U, Goransson I, Wollin R, Forsman M, Tarnvik A, Sjostedt A (2000) Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol 38:22-26
9. Johansson A, Berglund L, Gothefors L, Sjostedt A, Tarnivk A (2000) Ciprofloxacin for treatment of tularemia in children. Pediatr Infect Dis J 19:449-453
10. Kovářová H, Macela A, Stulík J (1990) The production of oxygen metabolites and their possible regulatory role in the course of tularemia infection. Folia Microbiol (Praha) 35:413-422
11. Limaye AP, Hooper CJ (1999) Treatment of tularemia with fluoroquinolones: two cases and review. Clin Infect Dis 29:922-924
12. Maranan MC, Schiff D, Johnson DC, Abrahams C, Wylam M, Gerber SI (1997) Pneumonic tularemia in a patient with chronic granulomatous disease. Clin Infect Dis 25:630-633
13. Naughton M, Brown R, Adkins D, DiPersio J (1999) Tularemia - an unusual cause of a solitary pulmonary nodule in the post-transplant setting. Bone Marrow Transplant 24:197-199
14. Penn RL, Kinasewitz GT (1987) Factors associated with a poor outcome in tularemia Arch Intern Med 147:265-268
15. Pérez-Castrillón JL, Bachiller-Luque P, Martín-Luquero M, Mena-Martín FJ, Herreros V (2001) Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis 33:573-576
16. Risi GF, Pombo DJ (1995) Relapse of tularemia after amino-glycoside therapy: case report and discussion of therapeutic options. Clin Infect Dis 20:174-175
17. Sjöstedt A, Conlan JW, North RJ (1994) Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect Immun 62:2779-2783
18. Tärnvik A (1989) Nature of protective immunity to Francisella tularensis. Rev Infect Dis 11:440-450
19. Waag DM, Sandström G, England MJ, Williams JC (1996) Immunogenicity of a new lot of Francisella tularensis live vaccine strain in human volunteers. FEMS Immunol Med Microbiol 13:205-209
20. Yee D, Rhinehart-Jones TR, Elkins KL (1996) Loss of either CD4+ or CD8+ does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J Immunol 157:5042-5048